162 related articles for article (PubMed ID: 37284981)
1. [Dermato-neuro syndrome-an acute and life-threatening complication of scleromyxedema Arndt-Gottron].
Linse KP; Enk A; Hoffmann J
Dermatologie (Heidelb); 2023 Aug; 74(8):618-620. PubMed ID: 37284981
[TBL] [Abstract][Full Text] [Related]
2. Dermato-neuro syndrome after COVID-19 infection in a patient with scleromyxoedema: Previously successful treatment with intravenous immunoglobulins.
Li Y; Wang H; Wang A; Zhao G
J Dermatol; 2024 Jan; 51(1):140-144. PubMed ID: 37830263
[TBL] [Abstract][Full Text] [Related]
3. [Dermato-neuro syndrome during scleromyxedema: efficacy of plasmapheresis and intravenous immunoglobulin].
Charles S; Hainaut E; Cante V; Valette C; Levillain P; Guillet G
Ann Dermatol Venereol; 2014; 141(8-9):523-7. PubMed ID: 25209816
[TBL] [Abstract][Full Text] [Related]
4. [Good response of scleromyxedema and dermato-neuro syndrome to treatment with intravenous immunoglobulins].
Bielsa I; Benvenutti F; Guinovart RM; Ferrándiz C
Actas Dermosifiliogr; 2012 May; 103(4):317-20. PubMed ID: 21917233
[TBL] [Abstract][Full Text] [Related]
5. Scleromyxedema and the dermato-neuro syndrome: case report and review of the literature.
Fleming KE; Virmani D; Sutton E; Langley R; Corbin J; Pasternak S; Walsh NM
J Cutan Pathol; 2012 May; 39(5):508-17. PubMed ID: 22515222
[TBL] [Abstract][Full Text] [Related]
6. Scleromyxedema.
Hoffmann JHO; Enk AH
J Dtsch Dermatol Ges; 2020 Dec; 18(12):1449-1467. PubMed ID: 33373143
[TBL] [Abstract][Full Text] [Related]
7. Acute Encephalitic Syndrome Induced by Scleromyxedema.
Magira EE; Malouchou A; Karathanasi V; Mavropoulou N; Siempos II; Vourlakou C; Sykaras A; Anastasiadis G
Am J Med Sci; 2020 Aug; 360(2):192-195. PubMed ID: 32540147
[TBL] [Abstract][Full Text] [Related]
8. [Monoclonal immunoglobulin (M-Ig) and skin diseases from the group of mucinoses--scleredema adultorum Buschke and scleromyxedema. Description of four cases and an overview of therapies].
Adam Z; Szturz P; Krejčí M; Vašků V; Pour L; Michalková E; Ševčíková S; Čermáková Z; Veselý K; Vaníček J; Pourová E; Král Z; Mayer J
Vnitr Lek; 2015 Dec; 61(12):1072-87. PubMed ID: 26806503
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of intravenous immunoglobulin in Arndt-Gottron scleromyxedema].
Lopez L; Wierzbicka-Hainaut E; Villers A; Guillet G
Ann Dermatol Venereol; 2009 Apr; 136(4):330-6. PubMed ID: 19361699
[TBL] [Abstract][Full Text] [Related]
10. Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin.
Rey JB; Luria RB
J Am Acad Dermatol; 2009 Jun; 60(6):1037-41. PubMed ID: 19249127
[TBL] [Abstract][Full Text] [Related]
11. Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema.
Mahévas T; Arnulf B; Bouaziz JD; Livideanu CB; Osio A; Servy A; Cribier B; Sassolas B; Jachiet M; Michel L; Aucouturier P; Lipsker D; Frances C; Sbidian E; Rybojad M; Descamps V; D'Incan M; Humbert P; Beylot-Barry M; Passeron T; de Moreuil C; Taha RY; Hermine O; Dupuy A; Barbarot S; Debarbieux S; Carpentier O; Brault F; Schmutz JL; Thomas-Beaulieu D; Modiano P; Zarnitsky C; Lifermann F; Baubion E; Limal N; Le Bras F; Le Moigne M; Tauber M; Talbot A; Prud'homme R; Peltier S; De Masson A; Battistella M; Bagot M; Mékinian A; Fain O
Blood; 2020 Apr; 135(14):1101-1110. PubMed ID: 32027747
[TBL] [Abstract][Full Text] [Related]
12. Early onset of scleromyxedema Arndt-Gottron associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins.
Kefi A; Jaziri F; Ben Abdelghani K; Turki S
Clin Case Rep; 2022 Aug; 10(8):e6122. PubMed ID: 35937020
[TBL] [Abstract][Full Text] [Related]
13. Scleromyxedema (Arndt - Gottron Syndrome) Developing Under Tenofovir Treatment for Hepatitis B: Unique Presentation in a Bulgarian Patient!
Temelkova I; Patterson JW; Tchernev G
Open Access Maced J Med Sci; 2019 Mar; 7(5):782-785. PubMed ID: 30962839
[TBL] [Abstract][Full Text] [Related]
14. Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.
Manousaridis I; Loeser C; Goerdt S; Hassel JC
Acta Dermatovenerol Alp Pannonica Adriat; 2010 Dec; 19(4):15-9. PubMed ID: 21390475
[TBL] [Abstract][Full Text] [Related]
15. Dermato-neuro syndrome in a case of scleromyxedema.
Savran Y; Akarsu S
Eur J Rheumatol; 2015 Dec; 2(4):160-162. PubMed ID: 27708955
[TBL] [Abstract][Full Text] [Related]
16. Scleromyxedema in a 21 year old female patient with acute lymphoblastic leukemia: a case report.
Rabee H; Tayem L; Gharbeyah M; Abugaber D
BMC Dermatol; 2020 Dec; 20(1):18. PubMed ID: 33276772
[TBL] [Abstract][Full Text] [Related]
17. Case for diagnosis. Lichen myxedematosus.
Rebellato PR; Carbonar MB; Tabuti NI; Rastelli GJ
An Bras Dermatol; 2016; 91(6):842-843. PubMed ID: 28099617
[TBL] [Abstract][Full Text] [Related]
18. Scleromyxedema with dermato-neuro syndrome.
Gonzalez J; Palangio M; Schwartz J; Klainer AS; Bisaccia E
J Am Acad Dermatol; 2000 May; 42(5 Pt 2):927-8. PubMed ID: 10767707
[TBL] [Abstract][Full Text] [Related]
19. Scleromyxedema Without Monoclonal Gammopathy Treated with Intravenous Immunoglobulins.
Letzelter M; Grimaux X
Acta Dermatovenerol Croat; 2021 Apr; 291(1):51-53. PubMed ID: 34477065
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2: A potential trigger of dermato-neuro syndrome in a patient with scleromyxedema.
Fritz M; Tinker D; Wessel AW; Morris GM; Goldenberg L; Fesler M; Rukmangadachar L; Hurley MY
JAAD Case Rep; 2021 Dec; 18():99-102. PubMed ID: 34778497
[No Abstract] [Full Text] [Related]
[Next] [New Search]
